Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sweegen Triumphs in Federal Court Appeal, Securing Victory Against PureCircle
-
ARCPOINT ANNOUNCES US$1.6 MILLION NON-BROKERED PRIVATE PLACEMENT
-
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios at December 31, 2023
-
ROSEN, THE FIRST FILING FIRM, Encourages EHang Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – EH
-
AutoZone Announces Completion of Leadership Transition Plan
-
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
-
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
-
Euro Manganese Announces Resignation of Board Member
-
Eldorado Gold Announces Appointment of Paul Ferneyhough as Executive Vice President and Chief Financial Officer
-
NOVATAE RISK GROUP LAUNCHES EXCLUSIVE SERVICE STATION PROGRAM
-
Processa Pharmaceuticals to Present at the Biotech Showcase 2024
-
Horizon Aircraft Announces Board of Directors for Post-Merger Public Company
-
Flash News: OKX Wallet now features intuitive access to inscriptions
-
Brown & Brown, Inc. announces 2023 fourth-quarter earnings release and conference call dates
-
Interfield Global Software Inc. Announces Further Closing of Private Placement Financing
-
Brown & Brown, Inc. announces 2023 fourth-quarter earnings release and conference call dates
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Pennant and John Muir Health Enter into a Home Health Joint Venture in the Bay Area, California
-
Innovative Food Holdings, Inc. Announces Transition in Chief Financial Officer Role
-
Apollomics to Present at the 2024 Biotech Showcase
-
O’Reilly Automotive, Inc. Announces Dates for Its Fourth Quarter and Full-Year 2023 Earnings Release and Conference Call
-
ARHT Media Inc. Issues Shares Related to Semi-Annual Interest Payment on Secured Subordinated Debentures
-
Covenant Logistics Group, Inc. Announces Timing of Fourth Quarter Earnings Release and Conference Call
-
Lands' End Announces Participation in the 26th Annual ICR Conference
-
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
-
Guggenheim Investments Announces January 2024 Closed-End Fund Distributions
-
Brookfield Renewable to Host Fourth Quarter 2023 Results Conference Call
-
Lands' End Announces Participation in the 26th Annual ICR Conference
-
Travere Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
GYDER® Surgical announces successful first surgical cases in India
-
AdTheorent to Present at the Needham Growth Conference
-
California Water Service Group Subsidiaries Complete Acquisitions of HOH Utilities in Hawaii, Monterey Water Company in New Mexico
-
J & J SNACK FOODS SCHEDULES CONFERENCE CALL TO DISCUSS FIRST QUARTER FINANCIAL RESULTS
-
Condo Owners Reciprocal Exchange, an HCI Group Sponsored Insurer, Secures ‘A’, Exceptional Rating From Demotech
-
J & J SNACK FOODS SCHEDULES CONFERENCE CALL TO DISCUSS FIRST QUARTER FINANCIAL RESULTS
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Generac Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GNRC
-
Wintrust Financial Corporation Announces Fourth Quarter and Full Year 2023 Earnings Release Schedule
-
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
-
Udemy to Present at Needham’s 2024 Annual Growth Conference
-
Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
PLBY Group to Participate in the 2024 ICR Conference
-
Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator
-
Biomea Fusion to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
EverQuote to Participate at the 26th Annual Needham Growth Conference
